Skip to content

Bone development in patients with spinal muscular atrophy (SMA)

Bone development in patients with spinal muscular atrophy (SMA)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00040328
Enrollment
400
Registered
2026-07-13
Start date
2018-09-25
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

G12.0 G12.1

Interventions

Group 1: For patients with SMA undergoing spinal fusion surgery, the bone and cartilage tissue obtained during the procedure, as well as blood, urine, and sputum samples, will be analyzed
in addition, patient data and clinical X-ray, MRI, and CT images (which are routinely obtained for the surgeries) will be evaluated. Group 2: From patients without SMA who undergo spinal fusion surger

Sponsors

Universitätsmedizin Göttingen
Lead Sponsor

Eligibility

Sex/Gender
All
Age
5 Years to 17 Years

Inclusion criteria

Inclusion criteria: Following appropriate counseling and informed consent, the study will include all children and adolescents between the ages of 5 and 17 with a spinal deformity and SMA or another underlying condition who are undergoing surgical correction in the Department of Pediatric Orthopedics at UMG.

Exclusion criteria

Exclusion criteria: Patients who do not meet the criteria listed above or who do not consent to participate in the study are excluded.

Design outcomes

Primary

MeasureTime frame
Bone and cartilage parameters analyzed using molecular biological and imaging methods, determined at a single time point (spinal fusion surgery during adolescence).

Secondary

MeasureTime frame
Correlation of bone and cartilage parameters with analyzed X-ray, MRI, and CT images, as well as patient data such as medication use, determined at a specific point in time (the time of spinal fusion surgery during adolescence).

Countries

Germany

Contacts

Public ContactAnna-Kathrin Hell

Universitätsmedizin Göttingen

anna.hell@med.uni-goettingen.de+49 551 39 68701

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Aug 10, 2026